Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0R6JG
|
|||
Former ID |
DIB018982
|
|||
Drug Name |
BIX 02188
|
|||
Synonyms |
BIX02188; BIX-02188
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C25H24N4O2
|
|||
Canonical SMILES |
CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N)O
|
|||
InChI |
1S/C25H24N4O2/c1-29(2)15-16-7-6-10-19(13-16)27-23(17-8-4-3-5-9-17)22-20-12-11-18(24(26)30)14-21(20)28-25(22)31/h3-14,28,31H,15H2,1-2H3,(H2,26,30)
|
|||
InChIKey |
WGPXKFOFEXJMBD-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1094614-84-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | ERK activator kinase 5 (MAP2K5) | Target Info | Inhibitor | [1] |
Panther Pathway | CCKR signaling map ST | |||
Pathway Interaction Database | ErbB1 downstream signaling | |||
Trk receptor signaling mediated by the MAPK pathway | ||||
WikiPathways | Insulin Signaling | |||
EGF/EGFR Signaling Pathway | ||||
MAPK Signaling Pathway | ||||
Focal Adhesion | ||||
Cardiac Hypertrophic Response | ||||
BDNF signaling pathway | ||||
Signaling Pathways in Glioblastoma | ||||
NGF signalling via TRKA from the plasma membrane | ||||
Integrin-mediated Cell Adhesion | ||||
MicroRNAs in cardiomyocyte hypertrophy |
References | Top | |||
---|---|---|---|---|
REF 1 | Identification of pharmacological inhibitors of the MEK5/ERK5 pathway. Biochem Biophys Res Commun. 2008 Dec 5;377(1):120-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.